Evaluation of Potential Therapeutic Options for COVID-19

被引：2

作者：

Austin, Daren ^{[1
]}

Okour, Malek ^{[1
]}

机构：

[1] GlaxoSmithKline Res & Dev Ltd, Clin Pharmacol Modelling & Simulat, 1250 S Collegeville Rd, Collegeville, PA 19426 USA

来源：

JOURNAL OF CLINICAL PHARMACOLOGY | 2020年 / 60卷 / 08期

关键词：

PHARMACOKINETICS;

D O I：

10.1002/jcph.1669

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：976 / 977

页数：2

共 11 条

[1]

[Anonymous], CLIN INFECT DIS

[2] The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro [J].

Caly, Leon ;

Druce, Julian D. ;

Catton, Mike G. ;

Jans, David A. ;

Wagstaff, Kylie M. .

ANTIVIRAL RESEARCH, 2020, 178

[3] Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine [J].

Daher, Andre ;

Aljayyoussi, Ghait ;

Pereira, Dhelio ;

Lacerda, Marcus V. G. ;

Alexandre, Marcia A. A. ;

Nascimento, Cristiana T. ;

Alves, Julio Castro ;

da Fonseca, Lais Bastos ;

Dias da Silva, Diego Medeiros ;

Pinto, Douglas Pereira ;

Rodrigues, Danielle Fonseca ;

Rios Silvino, Ana Carolina ;

de Sousa, Tais Nobrega ;

Alves de Brito, Cristiana Ferreira ;

ter Kuile, Feiko O. ;

Lalloo, David G. .

MALARIA JOURNAL, 2019, 18 (01)

[4]

European Medicines Agency (EMA), 2020, SUMM COMP US REMD

[5] THE TOLERANCE TO AND PHARMACOKINETICS OF PENCICLOVIR (BRL-39123A), A NOVEL ANTIHERPES AGENT, ADMINISTERED BY INTRAVENOUS-INFUSION TO HEALTHY-SUBJECTS [J].

FOWLES, SE ;

PIERCE, DM ;

PRINCE, WT ;

STANIFORTH, D .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 43 (05) :513-516

[6] Safety, tolerability, and pharmacokinetics of escalating high doses of ivermectin in healthy adult subjects [J].

Guzzo, CA ;

Furtek, CI ;

Porras, AG ;

Chen, C ;

Tipping, R ;

Clineschmidt, CM ;

Sciberras, DG ;

Hsieh, JYK ;

Lasseter, KC .

JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (10) :1122-1133

[7] Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs [J].

Jeon, Sangeun ;

Ko, Meehyun ;

Lee, Jihye ;

Choi, Inhee ;

Byun, Soo Young ;

Park, Soonju ;

Shum, David ;

Kim, Seungtaek .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (07)

[8] Pharmacokinetics of Hydroxychloroquine and Its Clinical Implications in Chemoprophylaxis against Malaria Caused by Plasmodium vivax [J].

Lim, Hyeong-Seok ;

Im, Jeong-Soo ;

Cho, Joo-Youn ;

Bae, Kyun-Seop ;

Klein, Terry A. ;

Yeom, Joon-Sup ;

Kim, Tae-Seon ;

Choi, Jae-Seon ;

Jang, In-Jin ;

Park, Jae-Won .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (04) :1468-1475

[9] A phase I study of niclosamide in combination with enzalutamide in men with castration-resistant prostate cancer [J].

Schweizer, Michael T. ;

Haugk, Kathleen ;

McKiernan, Jozefa S. ;

Gulati, Roman ;

Cheng, Heather H. ;

Maes, Jessica L. ;

Dumpit, Ruth F. ;

Nelson, Peter S. ;

Montgomery, Bruce ;

McCune, Jeannine S. ;

Plymate, Stephen R. ;

Yu, Evan Y. .

PLOS ONE, 2018, 13 (06)

[10] Favipiravir pharmacokinetics in Ebola-infected patients of the JIKI trial reveals concentrations lower than targeted [J].

Thi Huyen Tram Nguyen ;

Guedj, Jeremie ;

Anglaret, Xavier ;

Laouenan, Cedric ;

Madelain, Vincent ;

Taburet, Anne-Marie ;

Baize, Sylvain ;

Sissoko, Daouda ;

Pastorino, Boris ;

Rodallec, Anne ;

Piorkowski, Geraldine ;

Carazo, Sara ;

Conde, Mamoudou N. ;

Gala, Jean-Luc ;

Bore, Joseph Akoi ;

Carbonnelle, Caroline ;

Jacquot, Frederic ;

Raoul, Herve ;

Malvy, Denis ;

de lamballerie, Xavier ;

Mentre, France .

PLOS NEGLECTED TROPICAL DISEASES, 2017, 11 (02)

← 1 2 →